Horizant 300 mg Extended Release Oral Tablet
RxNorm 1482821 NDC Crossover

NDC Directory Crossover & Product Mapping

The following National Drug Codes (NDCs) are directly associated with the clinical concept for Horizant 300 mg Extended Release Oral Tablet (RxCUI 1482821). This crossover tool provides a verified mapping between standardized RxNorm clinical drug definitions and the specific manufactured products listed in the FDA NDC directory.

Healthcare professionals, pharmacists, and data analysts use this list to identify various brand names, labelers, and commercial packaging variations linked to this semantic clinical drug concept. Each entry below represents a commercial product that fulfills the requirements of this specific clinical identifier.

Manufacturer Quick Index

→ Azurity Pharmaceuticals, Inc. (formerly Arbor Pharmaceuticals) 2

Azurity Pharmaceuticals, Inc. (formerly Arbor Pharmaceuticals)

NDC Product
Human Prescription Drug

Horizant
NDC 53451-0101

Generic Name
Gabapentin Enacarbil
Dosage Form
Tablet, Extended Release
Route
Oral
Marketing
NDA
Active Listing
NDC Product
Human Prescription Drug

Horizant
NDC 53451-0103

Generic Name
Gabapentin Enacarbil
Dosage Form
Tablet, Extended Release
Route
Oral
Marketing
NDA
Active Listing